Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15109 | 662 | 29.3 | 54% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
283 | 18382 | EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ACSDKP | Author keyword | 65 | 81% | 6% | 39 |
2 | N ACETYL SERYL ASPARTYL LYSYL PROLINE | Author keyword | 18 | 83% | 2% | 10 |
3 | CHROMATIN PEPTIDES | Author keyword | 11 | 100% | 1% | 6 |
4 | HEMOREGULATORY PEPTIDE | Author keyword | 9 | 83% | 1% | 5 |
5 | AC SDKP | Author keyword | 8 | 56% | 2% | 10 |
6 | N ACETYL SERYL ASPARTYL LYSYL PROLINE AC SDKP | Author keyword | 8 | 100% | 1% | 5 |
7 | EPIDERMAL PENTAPEPTIDE | Author keyword | 4 | 75% | 0% | 3 |
8 | N ACETYL SER ASP LYS PRO | Author keyword | 4 | 75% | 0% | 3 |
9 | HEMATOREGULATORY | Author keyword | 3 | 100% | 0% | 3 |
10 | SK AND F 107647 | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACSDKP | 65 | 81% | 6% | 39 | Search ACSDKP | Search ACSDKP |
2 | N ACETYL SERYL ASPARTYL LYSYL PROLINE | 18 | 83% | 2% | 10 | Search N+ACETYL+SERYL+ASPARTYL+LYSYL+PROLINE | Search N+ACETYL+SERYL+ASPARTYL+LYSYL+PROLINE |
3 | CHROMATIN PEPTIDES | 11 | 100% | 1% | 6 | Search CHROMATIN+PEPTIDES | Search CHROMATIN+PEPTIDES |
4 | HEMOREGULATORY PEPTIDE | 9 | 83% | 1% | 5 | Search HEMOREGULATORY+PEPTIDE | Search HEMOREGULATORY+PEPTIDE |
5 | AC SDKP | 8 | 56% | 2% | 10 | Search AC+SDKP | Search AC+SDKP |
6 | N ACETYL SERYL ASPARTYL LYSYL PROLINE AC SDKP | 8 | 100% | 1% | 5 | Search N+ACETYL+SERYL+ASPARTYL+LYSYL+PROLINE+AC+SDKP | Search N+ACETYL+SERYL+ASPARTYL+LYSYL+PROLINE+AC+SDKP |
7 | EPIDERMAL PENTAPEPTIDE | 4 | 75% | 0% | 3 | Search EPIDERMAL+PENTAPEPTIDE | Search EPIDERMAL+PENTAPEPTIDE |
8 | N ACETYL SER ASP LYS PRO | 4 | 75% | 0% | 3 | Search N+ACETYL+SER+ASP+LYS+PRO | Search N+ACETYL+SER+ASP+LYS+PRO |
9 | HEMATOREGULATORY | 3 | 100% | 0% | 3 | Search HEMATOREGULATORY | Search HEMATOREGULATORY |
10 | SK AND F 107647 | 3 | 100% | 0% | 3 | Search SK+AND+F+107647 | Search SK+AND+F+107647 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SERASPENIDE | 45 | 94% | 2% | 16 |
2 | TETRAPEPTIDE ACSDKP | 41 | 69% | 5% | 35 |
3 | ASP LYS PRO | 29 | 52% | 6% | 40 |
4 | ACSDKP | 29 | 72% | 3% | 23 |
5 | HEMOREGULATORY PEPTIDE | 19 | 63% | 3% | 19 |
6 | AC SDKP | 16 | 53% | 3% | 21 |
7 | ASP CYS LYS | 15 | 88% | 1% | 7 |
8 | SYNTHETIC TETRAPEPTIDE ACSDKP | 11 | 100% | 1% | 6 |
9 | PROTEIN KINASE NII | 11 | 78% | 1% | 7 |
10 | STEM CELL PROLIFERATION | 10 | 19% | 7% | 49 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
INHIBITORY PEPTIDES IN HEMATOPOIESIS | 1995 | 28 | 43 | 67% |
Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis | 2013 | 6 | 81 | 37% |
Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): Opportunities for angiotensin-converting enzyme inhibitor design | 2013 | 2 | 53 | 64% |
Pathobiological aspects of the local bone marrow renin-angiotensin system: a review | 2010 | 10 | 44 | 64% |
The hematopoietic system: a new niche for the renin-angiotensin system | 2006 | 22 | 46 | 37% |
N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes | 2014 | 1 | 123 | 36% |
Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system | 2003 | 61 | 85 | 25% |
Ac-SDKP, a marker of the angiotensin-converting enzyme activity? | 2006 | 1 | 27 | 70% |
Acidic chromatin peptides. Molecular models and biological activity | 1995 | 2 | 6 | 100% |
Relevance of renin expression by real-time PCR in acute myeloid leukemia | 2006 | 8 | 30 | 37% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOL MED SCI HUMAN BIOL | 1 | 50% | 0.3% | 2 |
2 | SEZ FISIOL BIOFIS | 1 | 17% | 0.9% | 6 |
3 | ANTIINFECT THER EUT UNIT | 1 | 50% | 0.2% | 1 |
4 | MED BIOL MED BIOL | 1 | 50% | 0.2% | 1 |
5 | SEZ NUTR METAB | 1 | 50% | 0.2% | 1 |
6 | BOLTZMANN LEUKEMIA | 0 | 33% | 0.2% | 1 |
7 | CHEMOTHER Y HEMATOL DIS INTENS CARE | 0 | 33% | 0.2% | 1 |
8 | MOL BIOPHYSSINO FRANCE DRUG SCREENIN | 0 | 33% | 0.2% | 1 |
9 | UNITA COMPLICANZE DIABET | 0 | 33% | 0.2% | 1 |
10 | UNITA FISIOPATOL RENALE | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000192006 | BASIC CANC//SIALOGLYCOPEPTIDE//DENSITY INHIBITION |
2 | 0.0000117466 | BB 10010//CK BETA 8//STEM CELL INHIBITOR |
3 | 0.0000096999 | CD143//ANGIOTENSIN I CONVERTING ENZYME//TESTICULAR ACE |
4 | 0.0000095243 | B B RAT//CFU SD8//BURST PROMOTING ACTIVITY |
5 | 0.0000094712 | CELL AND TISSUE KINETICS//CELL TUMOUR BIOL//H 3 DT |
6 | 0.0000079950 | THYMOSIN BETA 4//PROTHYMOSIN ALPHA//THYMOSIN ALPHA 1 |
7 | 0.0000068736 | PCR GENE REARRANGEMENT//PH1 POSITIVE ALL//MED CLIN MOLEC BIOL |
8 | 0.0000068001 | POSTTRANSPLANT ERYTHROCYTOSIS//POST TRANSPLANT ERYTHROCYTOSIS//ERYTHROCYTOSIS |
9 | 0.0000062943 | HEMATOPOIETIC MICROENVIRONMENT//MARROW CULTURE//BONE MARROW STROMA |
10 | 0.0000056398 | COLONY PROMOTING ACTIVITY//PHOSPHOAMINO ACIDS//KIDNEY EXTRACT |